The current price of AUTL is $1.26 — it has decreased by 8.70% since the previous close. Data as of Nov 5, 2026.
AUTL is down 20.25% over the past week, down 31.15% over the past month and down 9.35% over the past year. The price is below its 200-day moving average of $1.67.
Autolus Therapeutics plc has a market capitalization of $335.36M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to Autolus Therapeutics plc include Legend Biotech Corporation, Allogene Therapeutics, Inc., Lyell Immunopharma, Inc., Century Therapeutics, Inc. and Fate Therapeutics, Inc.
In the latest trading session AUTL moved between $1.23 and $1.36, a range of 10.71% of its current price.
Over the past 52 weeks AUTL has traded between $1.18 and $2.58. The current price is 51.16% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.